"Developing novel treatments for Dormant Cancers - targeting resistance, metastasis, and relapse."

April 2, 2019                AACR Annual Meeting

 

Abstract Number: 3038

Implications of DYRK1B kinase in ovarian cancers and utilization of DYRK1B inhibitors as a novel therapeutic strategy for ovarian cancers

Session: Drug Resistance 4

Date and Time: Tuesday April 2, 2019; 8:00 a.m. - 12:00 p.m. EDT

Location:  Exhibit Hall B; Poster Section 12; Poster Board Number 30

February, 2019             Journal of Molecular Modeling

April 4, 2017                AACR Annual Meeting

January 11, 2016          8th Annual BIOTECH Showcase

Oral presentation

Date and Time:  January 13th 2016 8AM

Location: The Parc 55 San Francisco Track A